Evidence map›Paper›PMID 37468466›Full record

ArticleNature communications2023

Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.

Baptiste Lamarthée, Jasper Callemeyn, Yannick Van Herck, Asier Antoranz, Dany Anglicheau, Patrick Boada, Jan Ulrich Becker, Tim Debyser, Frederik De Smet, Katrien De Vusser and 21 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Integration of Bulk and Single-Cell RNA Sequencing Analyses in Biomedicine.International journal of molecular sciences · 2026
    Review
  4. Cell-cell crosstalk in kidney health and disease.Nature reviews. Nephrology · 2026
    Review
  5. Review
  6. Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Review
  8. Article
  9. BHLHE40 Orchestrates Effector Tissue-Resident Memory CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 7 institutions in 3 countries.

Baptiste Lamarthée *Department of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8417-1661
Jasper Callemeyn *Department of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Yannick Van Herck *Department of Oncology, Laboratory for Experimental Oncology, KU Leuven, Leuven, Belgium.
Asier Antoranz *Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.
Dany AnglicheauDepartment of Nephrology and Kidney Transplantation, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0001-5793-6174
Patrick BoadaDivision of Multi-Organ Transplantation, Department of Surgery, UCSF, 513 Parnassus, San Francisco, CA, USA.
Jan Ulrich BeckerInstitute of Pathology, University Hospital Cologne, Cologne, Germany.
Tim DebyserDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Frederik De SmetDepartment of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.ORCID 0000-0002-6669-3335
Katrien De VusserDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Maëva EloudzeriUniversité Paris Cité, Inserm U1151, Necker Enfants-Malades Institute, Paris, France.
Amelie FrankenVIB Center for Cancer Biology, Leuven, Belgium.
Wilfried GwinnerDepartment of Nephrology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-1703-893X
Priyanka KoshyDepartment of Imaging and Pathology, KU Leuven, Leuven, Belgium.ORCID 0000-0002-2313-5122
Dirk KuypersDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Diether LambrechtsVIB Center for Cancer Biology, Leuven, Belgium.ORCID 0000-0002-3429-302X
Pierre MarquetDepartment of Pharmacology and Transplantation, University of Limoges, Inserm U1248, Limoges University Hospital, Limoges, France.
Virginie MathiasEFS, HLA Laboratory, Décines, France.
Marion RabantUniversité Paris Cité, Inserm U1151, Necker Enfants-Malades Institute, Paris, France.
Minnie M SarwalDivision of Multi-Organ Transplantation, Department of Surgery, UCSF, 513 Parnassus, San Francisco, CA, USA.
Aleksandar SenevDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0002-6196-4669
Tara K SigdelDivision of Multi-Organ Transplantation, Department of Surgery, UCSF, 513 Parnassus, San Francisco, CA, USA.
Ben SprangersDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Olivier ThaunatUniversité Claude Bernard Lyon I, Inserm U1111, CNRS UMR5308, CIRI, Ecole Normale Supérieure de Lyon, Lyon, France.
Claire TinelDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Thomas Van BrusselVIB Center for Cancer Biology, Leuven, Belgium.
Amaryllis Van CraenenbroeckDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0003-4728-9406
Elisabet Van LoonDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9796-9157
Thibaut VauletDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium.
Francesca BosisioDepartment of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8874-2003
Maarten NaesensDepartment of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium. maarten.naesens@uzleuven.be.ORCID 0000-0002-5625-0792
KU Leuven · BEInserm · FRVIB-KU Leuven Center for Cancer Biology · BEHôpital Necker-Enfants Malades · FRUniversité Claude Bernard Lyon 1 · FRMedizinische Hochschule Hannover · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rejection remains the main cause of premature graft loss after kidney transplantation, despite the use of potent immunosuppression. This highlights the need to better understand the composition and the cell-to-cell interactions of the alloreactive inflammatory infiltrate. Here, we performed droplet-based single-cell RNA sequencing of 35,152 transcriptomes from 16 kidney transplant biopsies with varying phenotypes and severities of rejection and without rejection, and identified cell-type specific gene expression signatures for deconvolution of bulk tissue. A specific association was identified between recipient-derived FCGR3A+ monocytes, FCGR3A+ NK cells and the severity of intragraft inflammation. Activated FCGR3A+ monocytes overexpressed CD47 and LILR genes and increased paracrine signaling pathways promoting T cell infiltration. FCGR3A+ NK cells overexpressed FCRL3, suggesting that antibody-dependent cytotoxicity is a central mechanism of NK-cell mediated graft injury. Multiplexed immunofluorescence using 38 markers on 18 independent biopsy slides confirmed this role of FcγRIII+ NK and FcγRIII+ nonclassical monocytes in antibody-mediated rejection, with specificity to the glomerular area. These results highlight the central involvement of innate immune cells in the pathogenesis of allograft rejection and identify several potential therapeutic targets that might improve allograft longevity.

Indexed as

Graft RejectionKidneyAllograftsAntibodiesImmunity, InnateTransplantation, HomologousAntibodies

Identifiers

PMID37468466
PMCPMC10356785
OpenAlexW4384818874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.